Cargando…
Development of Viral Vectors for Use in Cardiovascular Gene Therapy
Cardiovascular disease represents the most common cause of mortality in the developed world but, despite two decades of promising pre-clinical research and numerous clinical trials, cardiovascular gene transfer has so far failed to demonstrate convincing benefits in the clinical setting. In this rev...
Autores principales: | Williams, Paul D., Ranjzad, Parisa, Kakar, Salik J., Kingston, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185614/ https://www.ncbi.nlm.nih.gov/pubmed/21994642 http://dx.doi.org/10.3390/v2020334 |
Ejemplares similares
-
Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018) -
Current gene therapy using viral vectors for chronic pain
por: Guedon, Jean-Marc G, et al.
Publicado: (2015) -
Development of Viral Vectors for Gene Therapy for Chronic Pain
por: Huang, Yu, et al.
Publicado: (2011) -
Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
por: Kim, Jinsun, et al.
Publicado: (2020) -
The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
por: Mata-Espinosa, Dulce, et al.
Publicado: (2023)